— Know what they know.
Not Investment Advice

PRTA NASDAQ

Prothena Corporation plc
1W: -0.9% 1M: +1.3% 3M: -1.9% YTD: -8.7% 1Y: -13.8% 3Y: -81.2% 5Y: -86.7%
$8.81
+0.41 (+4.88%)
After Hours: $8.75 (-0.06, -0.68%)
Weekly Expected Move ±6.8%
$7 $8 $8 $9 $9
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 41 · $431.2M mcap · 44M float · 1.18% daily turnover · Short 70% of daily vol
Credit Risk of going bust: lower than 83% of companies Debt: 1.6% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.01 (down 99.9%), Prothena Corporation plc would be worth roughly what it owes.
Total debt $7.0M against a stock market value of $431.2M.
Distance to default 10.45 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $3.0M (short-term plus half of long-term), stock volatility 47.4%; Altman Z'' 9.96. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$327M -40.3% ▼
5Y CAGR: -0.4%
Total Liabilities
$46M -23.0% ▼
5Y CAGR: -20.8%
Shareholders Equity
$280M -42.4% ▼
5Y CAGR: +8.8%
Cash & Investments
$308M -34.8% ▼
5Y CAGR: +0.8%
Total Debt
$14M +27.8% ▲
5Y CAGR: -4.9%
Net Debt
-$294M +36.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$579M$710M$619M$471M$308M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$579M$710M$619M$471M$308M
Net Receivables$13K$62K$5M$0$0
Inventory$0$0$0$0$0
Other Current Assets$766K$2M$3M$1M$8M
Total Current Assets$585M$719M$639M$485M$315M
Property, Plant & Equip.$14M$8M$16M$14M$10M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$860K$860K
Other Non-Current Assets$3M$13M$7M$4M$482K
Total Non-Current Assets$25M$39M$57M$62M$12M
Total Assets$609M$758M$696M$547M$327M
— Liabilities —
Accounts Payable$4M$9M$25M$8M$6M
Short-Term Debt$0$0$0$0$3M
Deferred Revenue$8M$11M$0$9M$3M
Other Current Liabilities$405K$503K$2M$29M$29M
Total Current Liabilities$33M$50M$57M$49M$41M
Long-Term Debt$0$0$0$0$5M
Other Non-Current Liab.$553K$553K$0$0-$5M
Total Non-Current Liabilities$110M$86M$78M$12M$5M
Total Liabilities$143M$136M$135M$60M$46M
— Equity —
Common Stock$466K$521K$537K$538K$538K
Retained Earnings-$716M-$833M-$980M-$1.1B-$1.3B
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$466M$622M$561M$487M$280M
Total Liabilities & Equity$609M$758M$696M$547M$327M
— Key Metrics —
Total Debt$12M$6M$12M$11M$14M
Net Debt-$567M-$704M-$607M-$461M-$294M
Total Investments$0$0$0$860K$860K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms